Literature DB >> 9929997

[Preliminary report of an epidemic tularemia outbreak in Valladolid].

P Bachiller Luque1, J L Pérez Castrillón, M Martín Luquero, F J Mena Martín, J de la Lama López-Areal, P Pérez Pascual, M A Mazón, V Herreros Guilarte.   

Abstract

We make here a preliminary report of the first 65 cases of tularemia diagnosed at our hospital pertaining to an epidemic outbreak occurred in the area served by the hospital. Diagnosis was made by the presence of a consistent clinical picture and the following laboratory criteria: antibody titre to. Francisella tularensis (tube agglutination) higher than or equal to 1/160, seroconversion or recovery of the microorganism from biological material. The mean age of our patients was 53.8 +/- 13.5 years and female sex predominated (45 women). Fever, lymph node enlargement, cutaneous ulcers, asthenia, and weight loss were the most common symptoms. The presentation clinical forms included: ulceroganglionar (69%), typhoidal (14%), ganglionar (12.5%), pneumonic (1.5%), oculoganglionar (1.5%) and atypical (1.5%). The analytical data did not show significant changes with the exception of erythrocyte sedimentation rate. Streptomycin was the antibiotic of choice, followed by ciprofloxacin and gentamicin. The failure rate was 22%, and ciprofloxacin was used for retreatment in twelve occasions and ofloxacin in 1 occasion with a good response. Tularemia is an infective disease which can become endemic in Spain and that should be considered by clinicians, particularly when unilateral enlarged lymph nodes, prolonged febrile syndromes, pharyngitis with negative culture, poor response to beta-lactams and atypical pneumonia are present.

Entities:  

Mesh:

Year:  1998        PMID: 9929997

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  8 in total

1.  Comparison of different PCR approaches for typing of Francisella tularensis strains.

Authors:  V A de la Puente-Redondo; N G del Blanco; C B Gutiérrez-Martín; F J García-Peña; E F Rodríguez Ferri
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 2.  The status of tularemia in Europe in a one-health context: a review.

Authors:  G Hestvik; E Warns-Petit; L A Smith; N J Fox; H Uhlhorn; M Artois; D Hannant; M R Hutchings; R Mattsson; L Yon; D Gavier-Widen
Journal:  Epidemiol Infect       Date:  2014-09-30       Impact factor: 4.434

3.  Complete genome sequence of Francisella tularensis subspecies holarctica FTNF002-00.

Authors:  Ravi D Barabote; Gary Xie; Thomas S Brettin; Steven H Hinrichs; Paul D Fey; Justin J Jay; Jennifer L Engle; Shubhada D Godbole; Jyothi M Noronha; Richard H Scheuermann; Liwei W Zhou; Christine Lion; Michael P Dempsey
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

4.  Discrimination of human pathogenic subspecies of Francisella tularensis by using restriction fragment length polymorphism.

Authors:  Rebecca Thomas; Anders Johansson; Brendan Neeson; Karen Isherwood; Anders Sjöstedt; Jill Ellis; Richard W Titball
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 5.  Tularemia.

Authors:  Jill Ellis; Petra C F Oyston; Michael Green; Richard W Titball
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

6.  A patient with a rapidly lethal pneumonia after a visit to a touristic area in rural Leon (Spain).

Authors:  M Valerio; F López-Medrano; I Regalado-Artamendi; P Muñoz; J M Aguado; E Bouza
Journal:  Rev Esp Quimioter       Date:  2018-06-28       Impact factor: 1.553

7.  Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate.

Authors:  Eun-Ju Kim; Sang-Hee Park; Young-Sill Choi; Soo-Kyoung Shim; Mi-Yeoun Park; Man Suck Park; Kyu-Jam Hwang
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

Review 8.  [Patient consent to "antimicrobial treatment of tonsillitis"].

Authors:  C Cenjor; J A García-Rodríguez; A Ramos; J Cervera; M Tomás; F Asensi; J L Cañada; M Gobernado; T Isasiá; C López-Madroñero; M Martínez; F Pérez-Escanilla; J Picazo; J Prieto; T Sampelayo
Journal:  Acta Otorrinolaringol Esp       Date:  2003-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.